JAK2 and hepatocellular carcinoma: Molecular docking simulations of various BSCA components with JAK2 and STAT3 proteins indicated specific components with higher binding affinities, suggesting their potential to induce apoptosis in hepatocellular carcinoma cells by modulating the JAK2/STAT3 pathway.